A novel non-invasive imaging tool for the early screening for Alzheimer’s disease.

Our solution is perfectly suited for the screening of the population above 50 years. As 40 percent of dementia are preventable by lifestyle changes, being able to screen the entire population could prevent ten million cases of Alzheimer’s. What is more, if an effective medication is put on the market (there are more than 20 phase 3 clinical trials for Alzheimer’s drugs currently), then patients could be treated in time, before their cognitive abilities decline.